Will Universal Health Services Beat These Analyst Estimates?
Universal Health Services (NYS: UHS) is expected to report Q4 earnings on Feb. 28. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Universal Health Services's revenues will increase 2.1% and EPS will expand 2.2%.
The average estimate for revenue is $1.88 billion. On the bottom line, the average EPS estimate is $0.93.
Last quarter, Universal Health Services logged revenue of $1.87 billion. GAAP reported sales were 3.0% higher than the prior-year quarter's $1.81 billion.
Last quarter, non-GAAP EPS came in at $0.91. GAAP EPS of $0.73 for Q3 were 15% lower than the prior-year quarter's $0.86 per share.
For the preceding quarter, gross margin was 44.9%, 150 basis points better than the prior-year quarter. Operating margin was 10.6%, 20 basis points worse than the prior-year quarter. Net margin was 3.8%, 90 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $7.51 billion. The average EPS estimate is $4.10.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 119 members out of 127 rating the stock outperform, and eight members rating it underperform. Among 42 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 40 give Universal Health Services a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Universal Health Services is outperform, with an average price target of $50.86.
Is Universal Health Services the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Universal Health Services to My Watchlist.
The article Will Universal Health Services Beat These Analyst Estimates? originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.